Full Year 2024 IMCD NV Earnings Call Transcript
Key Points
- IMCD NV (IMCDY) achieved a gross profit of EUR1,202 million and an operating EBITDA of EUR531 million, marking a 5% EBITDA increase on a constant currency basis compared to the previous year.
- The company completed 12 acquisitions in 2024, with a strong focus on life sciences, enhancing its portfolio and regional presence.
- IMCD NV (IMCDY) reported a healthy free cash flow of EUR450 million, leading to a cash earnings per share of EUR6.34.
- The company has a robust M&A pipeline and the financial means to execute targets, supported by a strong balance sheet and reasonable leverage levels.
- IMCD NV (IMCDY) continues to invest in digital and operational excellence, including the implementation of AI tools and enhancements to its digital commercial infrastructure.
- The company faced a challenging start to 2024 with a weak first quarter, impacting overall annual performance.
- Inflation and related cost increases could not be fully compensated, affecting the conversion margin, which decreased to 44.2% in 2024.
- In the EMEA region, macroeconomic factors negatively impacted performance, with inflation and geopolitical tensions contributing to a tougher business environment.
- The Asia-Pacific region experienced a decrease in gross profit margin due to lower-than-average margins from recent acquisitions.
- The company's dividend proposal reflects a 4% decrease compared to last year, indicating a cautious approach to maintaining balance sheet flexibility.
Ladies and gentlemen, hello, and welcome to the IMCD NV full-year 2024 results conference call. Please note this call is being recorded. (Operator Instructions)
I will now hand you over to your host, Valerie Diele-Braun, CEO, to begin today's conference. Thank you.
Good morning, everyone, and welcome to the IMCD 2024 full-year results. As usual, I'm here with my colleague Hans Kooijmans, the CFO of IMCD, who will lead you through the financial results after my preliminary remarks, and then we are open to answer your questions.
2024 was a challenging but successful year for IMCD. The global economy continued to grow at a modest pace, whilst geopolitical tensions and economic shifts influenced customer behavior. Nevertheless, we were able to recover from a rather weak first quarter to return to gross profit and EBITDA growth in all following quarters.
During 2024, we recorded a gross profit of EUR1,202 million and operating EBITDA
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
